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Abstract We describe clinical, morphologic, and immu-
nohistochemical features of 21 cases of solitary ﬁbrous
tumor presenting in the oral cavity. There were 9 male and
12 female patients with a median age of 51 years (range
37–83). The most common locations included the buccal
mucosa (the most common site), lip, maxillary or man-
dibular vestibule and tongue. Histopathologic examination
showed well-circumscribed tumors with two well-deﬁned
patterns: the classic pattern with densely cellular areas
alternating with hypocellular areas in a variably collage-
nous, vascular stroma and a more uniformly sclerotic pat-
tern with only subtle classic areas. The spindle-shaped
neoplastic cells consistently showed immunoreactivity for
antibodies directed against CD34. Five of nineteen cases
(26%) were reactive for CD99 and 19 of 19 for Bcl-2.
Follow-up information was available in 17 cases and
averaged 54 months, with no evidence of recurrence or
metastasis in any of these patients. Awareness that solitary
ﬁbrous tumor may present in the oral cavity is important so
that confusion with other spindle cell neoplasms can be
avoided. We also brieﬂy describe the differential diagnosis
and compare this series, the largest single series of intraoral
SFT, to cases previously reported in the literature.
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Introduction
In 1931, Klemperer and Rabin [1] described a series of
localized solitary pleural tumors arising from the sub-
pleural areolar tissue, and this report is thought to be the
ﬁrst description of what we now refer to as the solitary
ﬁbrous tumor (SFT). Since 1931, this entity has been
referred to as ﬁbrous mesothelioma, subpleural ﬁbroma and
localized ﬁbrous tumor of the pleura. The histogenesis of
the SFT has been controversial, with evidence supporting a
mesothelial origin being presented by Stout and Murray
[2], while an undifferentiated mesenchymal cell histogen-
esis was preferred by England et al. [3].
In support of a mesenchymal origin, spindle cell tumors
bearing a close resemblance to this localized pleural tumor
have been described in a variety of anatomic sites that are
not lined by mesothelium [4]. These include the orbit [5],
nasal cavity [6] salivary glands [7] and meninges [8]. SFT
is now the term most widely used to designate these
tumors. After revision of its pleural tumor classiﬁcation by
the World Health Organization (WHO) in 1999, SFT was
ﬁnally classiﬁed as an independent entity and was excluded
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the diagnosis of hemangiopericytoma (HPC) was called
into question [10][ 11], and in 2002, the WHO acknowl-
edged that the majority of tumors formerly diagnosed as
HPC could be reclassiﬁed as any number of other soft
tissue tumors including SFTs. Many pathologists now
believe that the diagnosis of HPC should be used only for
truly pericytic lesions, such as the sinonasal HPC [12].
The histological spectrum of SFT is broad, with
appearances often varying from ﬁeld-to-ﬁeld within one
tumor, thus contributing to diagnostic difﬁculties. Chan [4]
suggested several diagnostic criteria for SFT, namely:
1. Circumscription
2. Alternating hypercellular foci and hypocellular scle-
rotic foci
3. Short spindly or ovoid cells with scanty and poorly
deﬁned cytoplasm
4. Few mitotic ﬁgures (\4/10 HPF)
5. Intimate intertwining of thin or thick collagen ﬁbrils
with spindle cells
6. CD34 positivity of spindled cells
The aim of this study is to report 21 new cases of SFT of
the oral cavity, to evaluate the diagnostic features of these
tumors, and to correlate these features with immunohisto-
chemical ﬁndings.
Materials and methods
Twenty-one patients with oral and pharyngeal SFTs were
identiﬁed from the databases of the Division of Oral and
Maxillofacial Pathology, Harvard School of Dental Medi-
cine through Pathology Services Inc, Cambridge, MA
(N = 4), the Department of Pathology, Brigham and
Women’s Hospital, MA, Boston (N = 4), Paciﬁc Oral and
Maxillofacial Pathology Laboratory, San Francisco, CA,
Oral Pathology Diagnostic Services, San Diego, CA
(N = 8), Oral and Maxillofacial Pathology Biopsy Service
of the Ohio State University, Columbus, Ohio (N = 4) and
Division of Pathology, Texas A&M Health Science Center,
Baylor College of Dentistry, Dallas, Texas (N = 1). For
each case, clinical information was obtained from acces-
sion forms and follow-up was obtained from contributors.
Review of all cases was carried out by Drs. SB Woo
(Department of Pathology, Brigham and Womens Hospital,
Boston, MA) and CD Fletcher (Department of Pathology,
Brigham and Women’s Hospital, Boston, MA) and Dr.
Esther O’Regan, Visiting Scholar, Brigham and Womens
Hospital, Boston, MA. The diagnosis was conﬁrmed by
both microscopic features on hematoxylin-eosin staining
and by immunohistochemical analysis. Three original cases
were deemed to represent other entities and were excluded
from the study. Representative sections of the cases were
studied immunohistochemically with antibodies to CD34,
CD99, bcl-2, EMA, S-100 protein, smooth muscle actin
and AE1/AE3 using the avidin-biotin-peroxidase complex
method with appropriate controls (Table 1).
Results
Clinical Findings
The clinical features of the 21 patients are summarized in
Table 2. There were 12 men and 9 women, with a median
age of 51 years (range 37–83). The most common sites
were buccal mucosa (38%), vestibule (19%), lip (14%),
tongue (9%), gingiva/alveolar mucosa (9%) and one each
in the pharynx and infra-temporal fossa. The tumors
showed a predilection for the right side in 17 of 21 cases
(81%). All tumors were surgically excised. The tumor was
completely excised in only three of the cases. In the other
18 cases, the margin status was positive. Follow-up data
was available in 17 cases, and the period of follow-up
ranged from 3 months to 144 months (mean 54 months,
median 48 months). At time of follow-up, all 17 patients
were alive with no evidence of disease.
Table 1 Antibodies used for immunohistochemical studies
Antibody Clone Source Pre-treatment
CD34 Mouse anti-human IgG1/j QBEnd 10 Dako, Carpinteria, California None
CD99 Mouse anti-human IgG1 O13 Signet, Dedham, Massachusetts PC
Bcl-2 Mouse anti-human IgG1/j 124 Dako PC
Epithelial membrane antigen (EMA) Mouse anti-human IgG2a/j E29 Dako None
a-smooth muscle actin (SMA) Mouse anti-human IgG2a 1A4 Sigma, St. Louis, Missouri None
S-100 protein Rabbit anti-human Ig Polyclonal Dako None
Cytokeratin Mouse anti-human IgG1/j AE1/AE3 Dako Pr
PC pressure cooker antigen retrieval in 10 mM citrate buffer pH6.0, Pr digestion with 0.1% protease from Bacillus licheniformus (10 min at
37C)
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Grossly, the tumors ranged from 0.7 cm to 5.4 cm with
86% (18/21) of tumors 2.5 cm or less in greatest
dimension.
The microscopic ﬁndings are presented in Table 3. All
tumors exhibited circumscription and two were partially or
completely encapsulated (Case 1 and 3, respectively)
(Fig. 1a). Skeletal muscle trapping at the periphery was
evident in two cases, and in one of those cases, muscle was
seen deep within the substance of the tumor, and not just at
the periphery (Fig. 1b). All cases were characterized by a
proliferation of spindled cells in a variably vascular and
collagenized stroma.
Pattern
Two patterns were discerned. In the interest of not
continuing to perpetuate the term HPC for these lesions,
what used to be described as ‘‘HPC-like’’ will be referred
Table 2 Clinical features of 21 patients with oral SFT
Case Number Age (yrs) Sex Site Laterality Size (cm) Follow-up
1 83 F Vestibule R 1.2 LTF
2 57 M Tongue R 2.3 NED at 36 months
3 47 M Pharynx R 5.4 NED at 3 months
4 51 F Buccal mucosa R 1.5 LTF
5 60 M Lip R 2.5 NED at 84 months
6 69 M Vestibule R 0.9 LTF
7 46 M Vestibule R 4.0 NED at 21 months
8 58 M Alveolar mucosa R 1.0 NED at 58 months
9 51 F Buccal mucosa L 1.5 NED at 9 months
10 43 F Alveolar mucosa R 2.0 NED at 78 months
11 57 M Buccal mucosa R 2.1 NED at 62 months
12 43 F Buccal mucosa R 2.0 NED at 48 months
13 74 M Vestibule R 2.5 NED at 102 months
14 43 F Buccal mucosa R 0.8 NED at 90 months
15 47 F Tongue L 1.0 NED at 57 months
16 46 F Buccal mucosa R 2.5 NED at 30 months
17 54 M Lip R 0.7 NED at 27 months
18 48 M Lip L 1.5 LTF
19 64 M Infratemporal fossa
a L 3.5 NED at 39 months
20 44 M Buccal mucosa R 1.8 NED at 28 months
21 37 F Buccal mucosa R 1.0 NED at 144 months
LTF lost to follow up, NED No evidence of disease, R right, L Left, N/A not available
a This mass protruded slightly into the maxillary vestibule, but the bulk of it was in the infratemporal fossa
Fig. 1 a SFT with typical well-circumscribed appearance. Also shown here is fat entrapped within the tumor b Muscle entrapment is a feature
seen in SFTs
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of 21 cases, 62%) was the ‘‘classic SFT’’ pattern, deﬁned
by the consistent presence of numerous variably ectatic
thin-walled vessels, sometimes with a staghorn conﬁgura-
tion, in a background of a cellular spindle cell proliferation
with hyper- and hypo-cellular areas (Fig. 2). The spindled
cells often formed whorls around small capillaries in a
vaguely storiform pattern in hypercellular areas (Fig. 3a).
Delicately collagenized hypocellular and myxoid areas
were often seen around larger dilated vessels that occa-
sionally exhibited perivascular hyalinization that often
spread beyond the conﬁnes of the perivascular spaces (Case
12, 16) (Fig. 3b). In some areas, the collagen fascicles were
longer and streaming. Hyalinized collagen in the form of
‘‘ropey collagen’’ or collagen nodules was seen (Fig. 3c).
The term amianthoid ﬁbers have also been used to describe
this feature [4, 13]. Three of the thirteen cases had a pre-
dominantly hypercellular pattern (Cases 1, 7 and 15), and
in these cases the hypocellular areas were composed of
sclerotic collagen, rather than the looser, delicate collagen
or myxoid areas seen in the other ten tumors (Fig. 3d).
Myxoid zones dominated in one case (Case 18) (Fig. 4).
Case 20 showed the typical storiform spindle cell pro-
liferation and vasculature but was unusual in that these
areas of hypercellularity were sharply demarcated from the
hypocellular areas, the latter being uniformly myxoid
(Fig. 5).
The less common ‘‘sclerotic’’ pattern (8 of the 21 cases,
38%) was one of prominent ﬁbrosis, with only focal hy-
percellular or myxoid areas (Fig. 6). This pattern was
predominantly composed of sweeping fascicles of dense
collagen; the classic SFT pattern was noted only focally
and staghorn vessels were inconspicuous.
Fig. 2 Typical alternations of hypercellular and hypocellular areas in
a sclerotic background
Table 3 Histopathologic
features of twenty-one patients
with intraoral SFT
C Classic, CC Classic cellular, S
Sclerotic, G Giant cells, F Fat,
M Mast cells, L Lymphocytes
a Full or partial capsule
b Classic pattern with sharp
demarcation of hyper- and
hypocellular myxoid areas; this
unusual case is further described
in the results section
Case
number
Circumscribed Pattern Stroma Mitoses Other features
Y/N Classic/Classic
cellular/Sclerotic
Myxoid Hyalinized Number
per 10 hpf
Giant cells/Fat/Mast
cells/Lymphocytes
1Y
a CC -? 1–
2Y C ?- 0 G/L
3Y
a C ?? 0 G/F/M/L
4Y S ?? 0 M/L
5Y S ?? 0 G/L
6Y S -? 0 G/F/L
7Y C C -- 0L
8Y S ?? 0 M/L
9Y C -- 0 G/M/L
10 Y S -? 0 M/L
11 Y C ?- 2 G/F/L
12 Y C ?? 0L
13 Y S ?? 4L
14 Y S -? 0 F/L
15 Y CC -? 0L
16 Y C ?? 2L
17 Y C ?? 0 G/L
18 Y C ?? 0L
19 Y S -? 0L
20 Y C
b ?- 0L
21 Y C ?? 2 G/L
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Only a few remnant acini were noted and there was
prominent periductal hyalinization in both cases (Fig. 7).
Cytologic Features
The constituent cells were either spindle-shaped or ovoid,
with scant cytoplasm and indistinct cell borders. Nuclei
were ovoid, fusiform or even cigar-shaped in some cases
and had dispersed chromatin with small to inconspicuous
nucleoli (Fig. 8). Giant cells were present in 43% of cases
(in 6/13 of tumors with the ‘‘classic’’ pattern and 3/8 of
tumors with the ‘‘sclerotic’’ pattern) although they were
abundant in only one tumor (Case 17), which exhibited
numerous multinucleated giant cells, some with nuclear
irregularity and coarse chromatin (Fig. 9). Overall, there
were 0–3 mitoses per 10 high power ﬁelds. Mast cells were
seen in nine cases (43%). Scattered lymphocytes were
observed in all but one case, but only one case (Case 11)
Fig. 5 Case 20 is an unusual case, showing sharp demarcation
between hypercellular and hypocellular areas
Fig. 3 a Characteristic whorls found in the more hypercellular areas b Dense perivascular hyalinized material found in many of the classic cases
c Ropey collagen, a consistent feature of the classic pattern d Typical cellular appearance seen in three of the thirteen classic cases
Fig. 4 Case 18 showed a predominantly myxoid pattern
110 Head and Neck Pathol (2009) 3:106–115showed distinct foci of lymphocytes. Mature lipocytes
within the tumor were seen in four cases (19%).
Immunohistochemistry
The results of the immunohistochemical reactions are
reported in Table 4. In all but one case CD34 positivity
within the cytoplasm was at the 3? level of intensity. All
cases were also positive for bcl-2. Five cases (24%) were
immunopositive for CD99, at an intensity of 2? or less. No
immunoreactivity was seen with antibodies directed
against AE1/AE3, EMA, SMA and S100.
Discussion
The current consensus is that SFT is a mesenchymal neo-
plasm of ﬁbroblastic and not mesothelial origin [12, 14,
15]. The non-pleural tumors that resembled HPC as
described by Stout [2] are now mostly believed to represent
extra-pleural SFTs and many have abandoned HPC as a
diagnostic term in favor of the term SFT [12]. There is a
residual group of tumors that currently retain the diagnosis
of HPC and these include sinonasal HPC, which demon-
strates cells with true pericytic properties [16]. This group
of tumors of pericytic origin in future will likely be
reclassiﬁed as myopericytomas [6, 12].
A review of the literature revealed 58 cases of SFT in
the oral cavity to date, the vast majority of which have been
reported as single cases [17–22, 23–30, 19, 31–40, 41–44].
This series of 21 patients is the largest series of intraoral
SFT published to date. Table 5 summarizes some of the
ﬁndings in the literature and compares them to those of the
current study. Intraoral SFT occur with equal sex predi-
lection, over a wide age range with a predilection for the
Fig. 6 Thick eosinophilic collagen bundles typical of the sclerotic
appearance of some SFTs
Fig. 7 Remnant minor salivary ducts with prominent peri-ductal
hyalinization
Fig. 8 High power view showing the cytological features of SFT
Fig. 9 Multi-nucleated giant cells were seen in almost half of the
cases
Head and Neck Pathol (2009) 3:106–115 111sixth decade, and in a variety of sites [17, 18, 28, 45, 46]
Concurring with previous reports, the current study found
that the buccal mucosa remained the most frequent intra-
oral site of occurrence, followed by lip and tongue. This
case series showed a marked predilection of oral SFTs for
the right side (81%). Of note, Alawi et al. found in their
series of intraoral SFTs that 80% of cases occurred on the
left side [18]. This side predilection in both case series
probably reﬂects sample size, rather than being a truly
signiﬁcant clinical feature.
While we have no reports of a history of trauma in any
of these patients, there have been several previous publi-
cations recounting histories of trauma and it has been
suggested that trauma may impact the site predilection for
SFT within the oral cavity [18, 28]. Alawi et al. addressed
this in 2001, referring to the identiﬁcation by Bucala et al.
Table 4 Immunohistochemistry results
Case number CD34 CD99 Bcl-2 EMA SMA S-100 protein AE1/AE3 keratin
13 ? neg 3? neg neg neg neg
23 ? N/A N/A N/A neg neg neg
33 ? N/A N/A N/A neg neg neg
41 ? neg 1? neg neg neg neg
53 ? neg 3? neg neg neg neg
63 ? neg 3? neg neg neg neg
73 ? neg 3? neg neg neg neg
83 ? neg 3? neg neg neg neg
93 ? 1? 3? neg neg neg neg
10 3? neg 3? neg neg neg neg
11 3? neg 3? neg neg neg neg
12 3? 1? 3? neg neg neg neg
13 3? 1? 3? neg neg neg neg
14 3? neg 3? neg neg neg neg
15 3? neg 3? neg neg neg neg
16 3? neg 3? neg neg neg neg
17 3? neg 3? neg neg neg neg
18 3? 1? 3? neg neg neg neg
19 3? neg 3? neg neg neg neg
20 3? 2? 3? neg neg neg neg
21 3? neg 3? neg neg neg neg
Table 5 Comparison between
current series and previously
reported cases
a Clinical information was
unavailable in two of the 58
previously reported cases
Current series (N = 21) Previously reported cases (N = 56)
a
Gender ratio M:F 12:9 24:32
Age in years (range) Mean 53.4, Median 51 (37–83) Mean 53.7, Median 54.5 (19–94)
Site N (%)
Buccal mucosa 8 (38.1) 33 (58.9)
Vestibule 4 (19.2) –
Lip 3 (14.3) 2 (3.6)
Tongue 2 (9.5) 9 (16.1)
Alveolar Mucosa 2 (9.5) 3 (5.3)
Oropharynx 1(4.7) 1 (1.8)
Infratemporal fossa 1 (4.7) –
Retromolar – 2 (3.6)
Palate – 4 (7.1)
Floor of mouth – 2 (3.6)
Mean Size in cm (range) 1.98 (0.7–5.4) 2.4 (0.7–7.5)
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trauma and functioning as a tissue repair mediator [18, 47].
Alawi raises the possibility that these cells may have a role
in at least propagating these tumors at sites of trauma.
In our series, the most common histopathologic form of
SFT was the ‘‘classic’’ pattern that exhibited all the criteria
delineated by Chan [4]. Within this pattern, three of our
cases were primarily hypercellular, with less conspicuous
hypocellular/myxoid changes. The differential diagnoses
for this variant include leiomyoma, cellular nerve sheath
tumor, myoﬁbroma, nodular fasciitis, a low-grade sarcoma
[17] and monophasic synovial sarcoma [48].
In case 20, the hypocellular areas were extremely
myxoid and sharply demarcated from the hypercellular
spindle cell proliferation, an unusual ﬁnding. It is unclear
whether this warrants separate classiﬁcation as a ‘‘myxoid’’
form of SFT. The differential diagnoses of the more
myxoid forms of SFT include benign nerve sheath tumors,
low-grade myxoﬁbrosarcoma, low-grade liposarcoma,
myxoid synovial sarcoma and myxoid spindle cell lipoma
[49].
A ‘‘sclerotic’’ pattern of SFT was seen in eight of the 21
cases (38%). In this pattern, there were subtle areas of
hypercellularity and myxoid change, with the bulk of the
tumor composed of dense collagen with interspersed
spindle cells and occasional staghorn vessels. The differ-
ential diagnosis for this includes the desmoplastic ﬁbroma,
sclerotic ﬁbroma and myoﬁbroma [17].
An interesting observation in two cases in the current
study was involvement of minor salivary gland, which has
not been previously reported. In both cases, the tumor had a
lobular architecture with remnant salivary gland tissue
embedded within the substance of the tumor, suggesting
the tumor arose within the parenchyma of minor glands.
Both cases were classic SFTs and exhibited marked peri-
ductal hyalinization. SFT involving the major salivary
glands has been reported [7, 50, 51].
Mature adipocytes were seen in four cases (19%) in our
series and this has been previously reported [6, 52]. These
cases share features with the fat-containing variant of SFT
[12, 52]. When adipocytes are present, spindle cell lipoma
and myxoid liposarcoma must be considered.
Thirty-eight percent of our cases contained multinucle-
ated giant cells, as has been reported [5] and these were
prominent in case 21. Guillou et al. discussed the possible
overlap between SFT and giant cell angioﬁbromas (GCA),
and suggested that GCAs are in fact a giant cell-rich variant
of SFT. They showed that GCA has a wider distribution
than initially thought, involving not only the orbit (where
they tend to occur) but also other sites in the head and neck
[13].
The demonstration of mast cells in SFTs has been
reported previously [18, 36, 30]; we noted mast cells in
38% of our cases. However, mast cells are a feature of
other soft tissue lesions including schwannomas [53],
spindle cell lipomas [54], neuroﬁbromas [55] and vascular
tumors [56]. It has been hypothesized that in some soft
tissue tumors, mast cells are involved in the development
of sclerosis by releasing proteases in the intercellular
matrix and around blood vessels [57]. Of note, in the
current study, the mast cells were readily identiﬁed in the
sclerotic pattern.
Scattered lymphocytes were present in 90% of cases in
the current series but in only one case was the inﬁltrate
present multi-focally in clusters. It is not an unusual feature
on reviewing the literature. At least a sparse lymphocytic
inﬁltrate has been described by Alawi et al., while Lo
Muzio et al. described the presence of a chronic inﬂam-
matory inﬁltrate in some cases [18, 40].
Chan considered positive immunoreactivity for CD34
one of the fundamental criteria for diagnosis of an extra-
pleural SFT [4]. CD34 antigen is a 110-kDa transmem-
brane cell surface glycoprotein found on myeloid
progenitor cells but also noted in other tissues and neo-
plasms such as dermatoﬁbrosarcoma protruberans, Kaposi
sarcoma, epithelioid sarcoma, gastrointestinal stromal
tumors as well as the SFT. [58, 59]. CD34 has also been
reported to be positive in occasional leiomyomas and
leiomyosarcomas [59]. Studies have reported between 80-
100% CD34 positivity rate in SFTs, with the percentage
difference likely being related to antibody type [59–61]. In
the current series 100% of cases were CD34-and bcl-2-
positive, with the vast majority being strongly positive
(3?). Only one case showed weak (1?) immunoreactivity
for CD34. While bcl-2-positive immunoreactivity may be
helpful in differentiating SFT from mesothelioma, it is less
helpful for extra-pleural sites because other mesenchymal
tumors (such as schwannoma, gastrointestinal stromal
tumor, synovial sarcoma) may also be bcl-2-positive [62].
CD99 is variably immunopositive in SFTs, with reports
describing as many as 70% of cases positive [63, 15, 18].
The current study found CD99 to be positive in a mere 26%
of cases. On review of the literature, it is clear that CD99
immunopositivity in SFTs may be variable, and is not even
reported in some cases series [28, 46]. None of the 21 cases
showed features that may have represented malignant SFT,
such as marked cytological atypia, necrosis, C4 mitoses per
10 high power ﬁelds or inﬁltrative margins. [64]. The
characteristic immunophenotype for the SFT does not help
differentiate between benign and malignant types [61].
Overall, there are no histopathologic or immunopheno-
typical features that separate SFTs arising in the head and
neck from those arising at other sites.
Follow-up information available for 17 cases (average
54 months), showed no recurrence and no metastases.
Alawi et al. in their case series also saw no recurrence or
Head and Neck Pathol (2009) 3:106–115 113metastasis in the 10 cases where follow-up data was
available [18]. While it is believed that lesions located in
the mediastinum, abdomen, pelvis and retroperitoneum
may behave aggressively [65] it appears that the intraoral
SFT tends to follow a more benign non-recurring course,
similar to SFTs that occur in the limbs.
Conclusion
This report of 21 cases of SFT is the largest study of
intraoral SFTs in the English literature and conﬁrms ﬁnd-
ings reported by other investigators. Two patterns were
noted. The more common classic pattern consisted of small
capillary-like vessels as well as staghorn vessels with
mixed hyper- and hypo-cellular areas. The less common
sclerotic pattern was characterized primarily by dense
bands of collagen with only subtle hypercellular areas. The
spindled tumor cells were consistently positive for CD34
and also for Bcl-2.
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